BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 8 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,698,288 | -14.1% | 53,100 | -15.8% | 0.00% | 0.0% |
| Q2 2023 | $5,469,508 | -55.5% | 63,100 | -50.1% | 0.00% | -60.0% |
| Q1 2023 | $12,291,136 | -45.6% | 126,400 | -42.1% | 0.01% | -50.0% |
| Q4 2022 | $22,591,867 | +8.8% | 218,300 | -10.9% | 0.01% | +11.1% |
| Q3 2022 | $20,760,000 | +4.2% | 244,900 | +1.9% | 0.01% | +12.5% |
| Q2 2022 | $19,922,000 | – | 240,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Maven Securities LTD | 38,500 | $2,907,000 | 0.13% |
| BOOTHBAY FUND MANAGEMENT, LLC | 75 | $566,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 150,100 | $11,334,000 | 0.02% |
| SIMPLEX TRADING, LLC | 752 | $5,678,000 | 0.01% |
| IMC-Chicago, LLC | 57,700 | $4,357,000 | 0.01% |
| Worth Venture Partners, LLC | 4,500 | $13,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 43,400 | $3,277,000 | 0.00% |